Cargando…

The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Biyani, Chandra Shekhar, Palit, Victor, Daga, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174975/
https://www.ncbi.nlm.nih.gov/pubmed/32333991
http://dx.doi.org/10.1016/j.urology.2020.04.057
_version_ 1783524736749273088
author Biyani, Chandra Shekhar
Palit, Victor
Daga, Sunil
author_facet Biyani, Chandra Shekhar
Palit, Victor
Daga, Sunil
author_sort Biyani, Chandra Shekhar
collection PubMed
description
format Online
Article
Text
id pubmed-7174975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71749752020-04-22 The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic Biyani, Chandra Shekhar Palit, Victor Daga, Sunil Urology Article Elsevier Inc. 2020-07 2020-04-22 /pmc/articles/PMC7174975/ /pubmed/32333991 http://dx.doi.org/10.1016/j.urology.2020.04.057 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Biyani, Chandra Shekhar
Palit, Victor
Daga, Sunil
The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title_full The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title_fullStr The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title_full_unstemmed The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title_short The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
title_sort use of captopril—angiotensin converting enzyme (ace) inhibitor for cystinuria during covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174975/
https://www.ncbi.nlm.nih.gov/pubmed/32333991
http://dx.doi.org/10.1016/j.urology.2020.04.057
work_keys_str_mv AT biyanichandrashekhar theuseofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic
AT palitvictor theuseofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic
AT dagasunil theuseofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic
AT biyanichandrashekhar useofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic
AT palitvictor useofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic
AT dagasunil useofcaptoprilangiotensinconvertingenzymeaceinhibitorforcystinuriaduringcovid19pandemic